Kiviat N B, Critchlow C W, Holmes K K, Kuypers J, Sayer J, Dunphy C, Surawicz C, Kirby P, Wood R, Daling J R
Department of Pathology, University of Washington, Seattle.
AIDS. 1993 Jan;7(1):43-9. doi: 10.1097/00002030-199301000-00007.
To examine and quantify the association between anal squamous intraepithelial lesions (ASIL), anal human papillomavirus (HPV) infection and immunosuppression among HIV-seropositive and HIV-seronegative homosexual men.
Cross-sectional study among homosexual men presenting at a community-based clinic for HIV serologic screening.
Anal HPV DNA was detected in 55 and 23% of 285 HIV-seropositive and 204 HIV-seronegative men, respectively, by Southern transfer hybridization (STH) [odds ratio (OR), 4.0; 95% confidence interval (CI), 2.7-6.2], and in 92 and 78% by polymerase chain reaction (PCR) (OR, 3.1; 95% CI, 1.6-5.8). ASIL was noted in 26% of HIV-seropositive men and in 8% of HIV-seronegative men (compared with men with negative cytologic findings: OR, 5.6; 95% CI, 3.0-10.5), with high-grade lesions noted in 4% of HIV-seropositive and in 0.5% of HIV-seronegative men. Among HIV-infected men, ASIL, detection of specific anal HPV types, and detection of high levels of anal HPV DNA (i.e., levels of HPV DNA detectable by both STH and PCR) were all associated with immunosuppression. Nevertheless, HIV-seropositive men with CD4 counts > 500 x 10(6)/l had a higher prevalence of both anal HPV and ASIL than men without HIV infection. Overall, detection of HPV at high levels was associated with ASIL. However, after adjustment for level of detectable HPV DNA, the risk of ASIL among HIV-seropositive men with CD4 counts < 500 x 10(6)/l was increased 2.9-fold (95% CI, 1.4-6.2) over that of HIV-seropositive men with CD4 counts > 500 x 10(6)/l.
Given the high rates of ASIL in HIV-seronegative and both immunosuppressed and non-immunosuppressed HIV-seropositive homosexual men, natural history studies are now needed to assist in the development of strategies for the detection and management of such lesions. The increased prevalence of ASIL seen among immunosuppressed HIV-seropositive men may be the result of both a non-specific increase in productive HPV infection and HIV-induced immune alterations of HIV-related neoplasia.
检测并量化肛门鳞状上皮内病变(ASIL)、肛门人乳头瘤病毒(HPV)感染与HIV血清阳性及HIV血清阴性同性恋男性免疫抑制之间的关联。
在一家社区诊所进行HIV血清学筛查的同性恋男性中开展横断面研究。
通过Southern印迹杂交(STH),分别在285例HIV血清阳性男性中的55%以及204例HIV血清阴性男性中的23%检测到肛门HPV DNA(优势比[OR],4.0;95%置信区间[CI],2.7 - 6.2),通过聚合酶链反应(PCR)检测到的比例分别为92%和78%(OR,3.1;95% CI,1.6 - 5.8)。26%的HIV血清阳性男性以及8%的HIV血清阴性男性存在ASIL(与细胞学检查结果阴性的男性相比:OR,5.6;95% CI,3.0 - 10.5),4%的HIV血清阳性男性以及0.5%的HIV血清阴性男性存在高级别病变。在HIV感染男性中,ASIL、特定肛门HPV类型的检测以及高水平肛门HPV DNA(即通过STH和PCR均可检测到的HPV DNA水平)的检测均与免疫抑制相关。然而,CD4细胞计数>500×10⁶/l的HIV血清阳性男性中肛门HPV和ASIL的患病率高于未感染HIV的男性。总体而言,高水平HPV的检测与ASIL相关。但是,在调整可检测到的HPV DNA水平后,CD4细胞计数<500×10⁶/l的HIV血清阳性男性发生ASIL的风险比CD4细胞计数>500×10⁶/l的HIV血清阳性男性增加了2.9倍(95% CI,1.4 - 6.2)。
鉴于HIV血清阴性以及免疫抑制和非免疫抑制的HIV血清阳性同性恋男性中ASIL的高发生率,现在需要开展自然史研究,以协助制定此类病变的检测和管理策略。免疫抑制的HIV血清阳性男性中ASIL患病率增加可能是HPV感染增殖的非特异性增加以及HIV诱导的与HIV相关肿瘤免疫改变共同作用的结果。